Penumbra, Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference

December 20, 2016

ALAMEDA, Calif., Dec. 20, 2016 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that its management team is scheduled to present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Event:

35th Annual J.P. Morgan Healthcare Conference

Date:

Tuesday, January 10, 2017

Time:

4:30pm ET / 1:30pm PT

A webcast of the presentation will be available by visiting the investors section of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The company has a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.

Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300382148.html

SOURCE Penumbra, Inc.

IR Contact

investors@penumbrainc.com

Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502
USA